vs
Side-by-side financial comparison of Marygold Companies, Inc. (MGLD) and Precipio, Inc. (PRPO). Click either name above to swap in a different company.
Marygold Companies, Inc. is the larger business by last-quarter revenue ($7.6M vs $6.8M, roughly 1.1× Precipio, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -7.5%, a 15.2% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -4.5%). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -1.5%).
Marygold Companies, Inc. is a U.S.-headquartered diversified holding company that operates across three core segments: financial services, specialty manufacturing, and consumer goods. It primarily caters to North American markets, driving long-term value growth via strategic investment in, and operational optimization of, its portfolio of subsidiary entities.
Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.
MGLD vs PRPO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.6M | $6.8M |
| Net Profit | $-576.0K | $526.0K |
| Gross Margin | 74.0% | 45.9% |
| Operating Margin | -8.3% | 7.9% |
| Net Margin | -7.5% | 7.7% |
| Revenue YoY | -4.5% | 28.4% |
| Net Profit YoY | 67.0% | 244.1% |
| EPS (diluted) | $-0.01 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.6M | $6.8M | ||
| Q3 25 | $7.0M | $6.9M | ||
| Q2 25 | $7.2M | $5.6M | ||
| Q1 25 | $7.0M | $4.9M | ||
| Q4 24 | $8.0M | $5.3M | ||
| Q3 24 | $7.9M | $5.3M | ||
| Q2 24 | $8.3M | $4.5M | ||
| Q1 24 | $7.9M | $3.5M |
| Q4 25 | $-576.0K | $526.0K | ||
| Q3 25 | $-356.0K | $-79.0K | ||
| Q2 25 | $-1.5M | $74.0K | ||
| Q1 25 | $-1.0M | $-884.0K | ||
| Q4 24 | $-1.7M | $-365.0K | ||
| Q3 24 | $-1.6M | $-626.0K | ||
| Q2 24 | $-1.9M | $-1.2M | ||
| Q1 24 | $-529.0K | $-2.1M |
| Q4 25 | 74.0% | 45.9% | ||
| Q3 25 | 77.0% | 43.6% | ||
| Q2 25 | 67.8% | 43.2% | ||
| Q1 25 | 75.0% | 43.6% | ||
| Q4 24 | 74.1% | 49.8% | ||
| Q3 24 | 73.1% | 43.1% | ||
| Q2 24 | 72.5% | 38.1% | ||
| Q1 24 | 70.5% | 26.5% |
| Q4 25 | -8.3% | 7.9% | ||
| Q3 25 | -18.2% | -0.9% | ||
| Q2 25 | -16.5% | -14.6% | ||
| Q1 25 | -21.4% | -17.5% | ||
| Q4 24 | -22.8% | -6.3% | ||
| Q3 24 | -27.4% | -11.3% | ||
| Q2 24 | -33.3% | -26.8% | ||
| Q1 24 | -18.7% | -59.6% |
| Q4 25 | -7.5% | 7.7% | ||
| Q3 25 | -5.1% | -1.1% | ||
| Q2 25 | -20.4% | 1.3% | ||
| Q1 25 | -14.4% | -18.0% | ||
| Q4 24 | -21.8% | -6.9% | ||
| Q3 24 | -20.1% | -11.9% | ||
| Q2 24 | -22.5% | -27.1% | ||
| Q1 24 | -6.7% | -59.8% |
| Q4 25 | $-0.01 | $0.36 | ||
| Q3 25 | $-0.01 | $-0.05 | ||
| Q2 25 | $-0.04 | $0.05 | ||
| Q1 25 | $-0.02 | $-0.59 | ||
| Q4 24 | $-0.04 | $-0.22 | ||
| Q3 24 | $-0.04 | $-0.42 | ||
| Q2 24 | $-0.05 | $-0.83 | ||
| Q1 24 | $-0.01 | $-1.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $2.7M |
| Total DebtLower is stronger | — | $83.0K |
| Stockholders' EquityBook value | $22.7M | $14.6M |
| Total Assets | $27.8M | $21.3M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $2.7M | ||
| Q3 25 | $12.5M | $2.3M | ||
| Q2 25 | $12.8M | $1.1M | ||
| Q1 25 | $15.6M | $1.0M | ||
| Q4 24 | $14.9M | $1.4M | ||
| Q3 24 | $17.5M | $1.1M | ||
| Q2 24 | $15.0M | $1.3M | ||
| Q1 24 | $16.1M | $776.0K |
| Q4 25 | — | $83.0K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $383.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $22.7M | $14.6M | ||
| Q3 25 | $22.9M | $13.7M | ||
| Q2 25 | $23.0M | $12.3M | ||
| Q1 25 | $24.3M | $11.7M | ||
| Q4 24 | $23.4M | $12.1M | ||
| Q3 24 | $25.5M | $11.9M | ||
| Q2 24 | $26.6M | $12.1M | ||
| Q1 24 | $28.4M | $12.8M |
| Q4 25 | $27.8M | $21.3M | ||
| Q3 25 | $28.4M | $21.2M | ||
| Q2 25 | $30.4M | $18.8M | ||
| Q1 25 | $33.5M | $17.8M | ||
| Q4 24 | $33.0M | $17.0M | ||
| Q3 24 | $35.9M | $17.0M | ||
| Q2 24 | $32.9M | $17.3M | ||
| Q1 24 | $33.7M | $16.6M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-908.0K | $366.0K |
| Free Cash FlowOCF − Capex | — | $291.0K |
| FCF MarginFCF / Revenue | — | 4.3% |
| Capex IntensityCapex / Revenue | 0.0% | 1.1% |
| Cash ConversionOCF / Net Profit | — | 0.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $359.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-908.0K | $366.0K | ||
| Q3 25 | $-533.0K | $10.0K | ||
| Q2 25 | $-3.3M | $353.0K | ||
| Q1 25 | $-1.2M | $-44.0K | ||
| Q4 24 | $-770.0K | $565.0K | ||
| Q3 24 | $-893.0K | $41.0K | ||
| Q2 24 | $-1.9M | $500.0K | ||
| Q1 24 | $-658.0K | $-667.0K |
| Q4 25 | — | $291.0K | ||
| Q3 25 | $-562.0K | $-44.0K | ||
| Q2 25 | $-3.4M | $294.0K | ||
| Q1 25 | — | $-182.0K | ||
| Q4 24 | $-776.0K | — | ||
| Q3 24 | $-940.0K | $-68.0K | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 4.3% | ||
| Q3 25 | -8.1% | -0.6% | ||
| Q2 25 | -46.8% | 5.2% | ||
| Q1 25 | — | -3.7% | ||
| Q4 24 | -9.7% | — | ||
| Q3 24 | -11.9% | -1.3% | ||
| Q2 24 | -23.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 0.4% | 0.8% | ||
| Q2 25 | 0.7% | 1.0% | ||
| Q1 25 | 0.0% | 2.8% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.6% | 2.1% | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | — | 0.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGLD
| Fund Management Related Party | $4.6M | 60% |
| Food Products | $1.7M | 22% |
| Beauty Products | $1.2M | 15% |
| Other | $268.0K | 4% |
PRPO
Segment breakdown not available.
